Supreme Court seems likely to preserve access to the abortion medication mifepristone
March 27, 2024
WASHINGTON (AP) — The Supreme Court on Tuesday seemed likely to preserve access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court's first abortion case since conservative justices overturned Roe v. Wade two years ago.
In nearly 90 minutes of arguments, a consensus appeared to emerge that the abortion opponents who challenged the FDA's approval of the medication, mifepristone, and subsequent actions to ease access to it lack the legal right, or standing, to sue.
Such a decision would leave the current rules in place that allow patients to re...
For access to this article please
sign in or
subscribe.
Reader Comments(0)